Papers/PMID:26265293
Dietary intake of iron, zinc, copper, and risk of Parkinson's disease: a meta-analysis.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2015The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
Zn(2+) — no detected effect on parkinson's disease incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“The pooled RRs of Parkinson's disease for moderate or high intake of zinc, and copper were not statistically different (P > 0.05).”
Quoted verbatim from Dietary intake of iron, zinc, copper, and risk of Parkinson's disease: a meta-analysis.. - Study
- meta-analysis
- Dose
- moderate or high dietary zinc intake versus lowest
- Population
- Participants in five observational studies (126,507 individuals) of dietary intake; moderate or high versus lowest intake
Dietary intake of iron, zinc, copper, and risk of Parkinson's disease: a meta-analysis.2015PMID:26265293Permalink